US Stock MarketDetailed Quotes

Beam Therapeutics (BEAM)

Watchlist
  • 31.607
  • -0.443-1.38%
Trading Jan 16 11:43 ET
3.21BMarket Cap-6.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics (BEAM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-32.03%9.7M
-28.08%8.47M
0.81%7.47M
-83.18%63.52M
-90.49%30.07M
-17.01%14.27M
-41.48%11.77M
-69.39%7.41M
520.01%377.71M
1,478.04%316.19M
Operating revenue
-32.03%9.7M
-28.08%8.47M
0.81%7.47M
-83.18%63.52M
-90.49%30.07M
-17.01%14.27M
-41.48%11.77M
-69.39%7.41M
520.01%377.71M
1,478.04%316.19M
Cost of revenue
Gross profit
Operating expense
13.03%136.51M
10.24%128.62M
13.64%126.76M
-13.55%479.09M
-29.03%130.1M
-3.74%120.77M
-4.58%116.67M
-9.42%111.54M
38.76%554.19M
68.16%183.33M
Selling and administrative expenses
0.85%26.74M
-9.34%26.86M
4.55%27.94M
-4.53%111.53M
-33.74%28.66M
4.35%26.52M
20.16%29.63M
13.77%26.72M
33.04%116.81M
90.72%43.26M
-General and administrative expense
0.85%26.74M
-9.34%26.86M
4.55%27.94M
-4.53%111.53M
-33.74%28.66M
4.35%26.52M
20.16%29.63M
13.77%26.72M
33.04%116.81M
90.72%43.26M
Research and development costs
16.46%109.77M
16.91%101.76M
16.50%98.82M
-15.96%367.56M
-27.58%101.44M
-5.79%94.26M
-10.83%87.04M
-14.88%84.82M
40.37%437.38M
62.24%140.08M
Operating profit
-19.07%-126.81M
-14.54%-120.15M
-14.55%-119.29M
-135.47%-415.57M
-175.30%-100.04M
1.63%-106.5M
-2.69%-104.9M
-5.26%-104.13M
47.86%-176.49M
249.30%132.86M
Net non-operating interest income expense
-10.09%10.9M
-13.14%12.33M
-16.75%9.86M
5.18%49.09M
-9.42%10.93M
-4.50%12.13M
18.71%14.19M
18.95%11.85M
205.13%46.68M
58.51%12.06M
Non-operating interest income
----
----
----
----
----
-4.50%12.13M
----
----
----
----
Total other finance cost
10.09%-10.9M
13.14%-12.33M
16.75%-9.86M
-5.18%-49.09M
---10.93M
---12.13M
-18.71%-14.19M
-18.95%-11.85M
-205.13%-46.68M
----
Other net income (expense)
238.80%3.18M
1,902.61%5.53M
102.38%152K
-656.58%-10.23M
-64.03%-1.25M
-341.43%-2.29M
-104.14%-307K
14.77%-6.39M
-102.15%-1.35M
-101.72%-759K
Gain on sale of security
196.29%2.18M
366.63%5.56M
102.86%179K
-6.57%-11.82M
53.55%-1.22M
65.28%-2.26M
-139.75%-2.09M
13.12%-6.25M
-125.15%-11.09M
-110.67%-2.62M
Special income (charges)
3,803.70%1M
-101.57%-28K
79.70%-27K
-83.66%1.59M
-101.45%-27K
-100.45%-27K
-18.06%1.78M
55.07%-133K
-48.48%9.74M
-90.42%1.86M
-Less：Restructuring and merger&acquisition
-3,803.70%-1M
101.57%28K
-79.70%27K
83.66%-1.59M
101.45%27K
100.45%27K
18.06%-1.78M
-55.07%133K
48.48%-9.74M
90.42%-1.86M
Income before tax
-16.61%-112.73M
-12.39%-102.29M
-10.74%-109.27M
-187.21%-376.7M
-162.67%-90.35M
-0.60%-96.67M
-9.95%-91.01M
-2.29%-98.67M
49.59%-131.16M
485.99%144.16M
Income tax
0
0
-97.14%39K
0
0
39K
-59.94%1.37M
36.60%1.37M
Earnings from equity interest net of tax
----
----
----
--0
----
----
----
----
--0
----
Net income
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-184.28%-376.74M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
Net income continuous Operations
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-184.28%-376.74M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
Minority interest income
Net income attributable to the parent company
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-184.28%-376.74M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.61%-112.73M
-12.34%-102.29M
-10.74%-109.27M
-184.28%-376.74M
-163.27%-90.35M
-0.60%-96.67M
-10.00%-91.05M
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
Basic earnings per share
5.98%-1.1
9.91%-1
-2.48%-1.24
-166.28%-4.58
-161.58%-1.09
4.10%-1.17
-2.78%-1.11
9.02%-1.21
58.35%-1.72
427.78%1.77
Diluted earnings per share
5.98%-1.1
9.91%-1
-2.48%-1.24
-166.28%-4.58
-163.01%-1.09
4.10%-1.17
-2.78%-1.11
9.02%-1.21
58.35%-1.72
420.37%1.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -32.03%9.7M-28.08%8.47M0.81%7.47M-83.18%63.52M-90.49%30.07M-17.01%14.27M-41.48%11.77M-69.39%7.41M520.01%377.71M1,478.04%316.19M
Operating revenue -32.03%9.7M-28.08%8.47M0.81%7.47M-83.18%63.52M-90.49%30.07M-17.01%14.27M-41.48%11.77M-69.39%7.41M520.01%377.71M1,478.04%316.19M
Cost of revenue
Gross profit
Operating expense 13.03%136.51M10.24%128.62M13.64%126.76M-13.55%479.09M-29.03%130.1M-3.74%120.77M-4.58%116.67M-9.42%111.54M38.76%554.19M68.16%183.33M
Selling and administrative expenses 0.85%26.74M-9.34%26.86M4.55%27.94M-4.53%111.53M-33.74%28.66M4.35%26.52M20.16%29.63M13.77%26.72M33.04%116.81M90.72%43.26M
-General and administrative expense 0.85%26.74M-9.34%26.86M4.55%27.94M-4.53%111.53M-33.74%28.66M4.35%26.52M20.16%29.63M13.77%26.72M33.04%116.81M90.72%43.26M
Research and development costs 16.46%109.77M16.91%101.76M16.50%98.82M-15.96%367.56M-27.58%101.44M-5.79%94.26M-10.83%87.04M-14.88%84.82M40.37%437.38M62.24%140.08M
Operating profit -19.07%-126.81M-14.54%-120.15M-14.55%-119.29M-135.47%-415.57M-175.30%-100.04M1.63%-106.5M-2.69%-104.9M-5.26%-104.13M47.86%-176.49M249.30%132.86M
Net non-operating interest income expense -10.09%10.9M-13.14%12.33M-16.75%9.86M5.18%49.09M-9.42%10.93M-4.50%12.13M18.71%14.19M18.95%11.85M205.13%46.68M58.51%12.06M
Non-operating interest income ---------------------4.50%12.13M----------------
Total other finance cost 10.09%-10.9M13.14%-12.33M16.75%-9.86M-5.18%-49.09M---10.93M---12.13M-18.71%-14.19M-18.95%-11.85M-205.13%-46.68M----
Other net income (expense) 238.80%3.18M1,902.61%5.53M102.38%152K-656.58%-10.23M-64.03%-1.25M-341.43%-2.29M-104.14%-307K14.77%-6.39M-102.15%-1.35M-101.72%-759K
Gain on sale of security 196.29%2.18M366.63%5.56M102.86%179K-6.57%-11.82M53.55%-1.22M65.28%-2.26M-139.75%-2.09M13.12%-6.25M-125.15%-11.09M-110.67%-2.62M
Special income (charges) 3,803.70%1M-101.57%-28K79.70%-27K-83.66%1.59M-101.45%-27K-100.45%-27K-18.06%1.78M55.07%-133K-48.48%9.74M-90.42%1.86M
-Less：Restructuring and merger&acquisition -3,803.70%-1M101.57%28K-79.70%27K83.66%-1.59M101.45%27K100.45%27K18.06%-1.78M-55.07%133K48.48%-9.74M90.42%-1.86M
Income before tax -16.61%-112.73M-12.39%-102.29M-10.74%-109.27M-187.21%-376.7M-162.67%-90.35M-0.60%-96.67M-9.95%-91.01M-2.29%-98.67M49.59%-131.16M485.99%144.16M
Income tax 00-97.14%39K0039K-59.94%1.37M36.60%1.37M
Earnings from equity interest net of tax --------------0------------------0----
Net income -16.61%-112.73M-12.34%-102.29M-10.74%-109.27M-184.28%-376.74M-163.27%-90.35M-0.60%-96.67M-10.00%-91.05M-2.29%-98.67M54.16%-132.53M472.36%142.8M
Net income continuous Operations -16.61%-112.73M-12.34%-102.29M-10.74%-109.27M-184.28%-376.74M-163.27%-90.35M-0.60%-96.67M-10.00%-91.05M-2.29%-98.67M54.16%-132.53M472.36%142.8M
Minority interest income
Net income attributable to the parent company -16.61%-112.73M-12.34%-102.29M-10.74%-109.27M-184.28%-376.74M-163.27%-90.35M-0.60%-96.67M-10.00%-91.05M-2.29%-98.67M54.16%-132.53M472.36%142.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.61%-112.73M-12.34%-102.29M-10.74%-109.27M-184.28%-376.74M-163.27%-90.35M-0.60%-96.67M-10.00%-91.05M-2.29%-98.67M54.16%-132.53M472.36%142.8M
Basic earnings per share 5.98%-1.19.91%-1-2.48%-1.24-166.28%-4.58-161.58%-1.094.10%-1.17-2.78%-1.119.02%-1.2158.35%-1.72427.78%1.77
Diluted earnings per share 5.98%-1.19.91%-1-2.48%-1.24-166.28%-4.58-163.01%-1.094.10%-1.17-2.78%-1.119.02%-1.2158.35%-1.72420.37%1.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.10%
Sample Name
Sample Code
 +2.86%
Sample Name
Sample Code
 +2.50%
4
Broadcom
AVGO
+1.39%
5
Microsoft
MSFT
+0.93%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.40%
Sample Name
Sample Code
 +9.98%
Sample Name
Sample Code
 +8.92%
4
Kingsoft Cloud
KC
+6.72%
5
Taiwan Semiconductor
TSM
+6.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -